Lv1
70 积分 2021-12-21 加入
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
2小时前
已完结
Rational combinations of targeted cancer therapies: background, advances and challenges
2小时前
已完结
The landscape for radioligand therapies in oncology
2小时前
已完结
Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
8小时前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
1个月前
已完结
Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis
1个月前
已完结
Targeting P4HA1 promotes CD8+ T cell progenitor expansion toward immune memory and systemic anti-tumor immunity
1个月前
已完结
Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trial
1个月前
已完结
Tertiary lymphoid structures in cancer
1个月前
已完结
TOX is a critical regulator of tumour-specific T cell differentiation
2个月前
已完结
皖公网安备34019202002308
